Johns Hopkins Kimmel Cancer Center;Janis Taube;Julie Stein Deutsch;Lung Cancer;Immunotherapy;CheckMate 816 study;residual viable tumor (RVT)

Pathologic Scoring Shows Promise for Assessing Lung Tumor Therapy Response

November 4, 2023 · Breaking News

**EMBARGOED UNTIL 8 P.M. ET SATURDAY, NOV. 4** Newswise — A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives…